CBAK Energy Technology, Inc. — FY2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual report; it does not provide standalone fourth-quarter results. The company manufactures high-power lithium batteries and, following its 2021 acquisition of Hitrans, cathode materials and precursors. Operations are conducted primarily through subsidiaries in China.
Financial performance and position
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $248.7 million | $52.7 million |
| Gross profit / margin | $18.1 million / 7.3% | $5.1 million / 9.7% |
| Operating loss | $11.5 million | $11.7 million |
| Consolidated net income (loss) | $(11.3) million | $61.6 million |
| Net income (loss) attributable to CBAK shareholders | $(9.4) million | $61.5 million |
| Operating cash flow | $15.1 million | $(4.3) million |
| Investing cash flow | $(7.9) million | $(38.1) million |
| Financing cash flow | $5.6 million | $48.3 million |
- Revenue increased 372%, primarily reflecting a full year of Hitrans results and higher battery sales. Materials revenue was $154.0 million; battery revenue was $94.7 million, including $83.6 million from uninterruptible power supply products.
- Gross margin fell from 9.7% to 7.3%, which management attributed largely to higher battery raw-material prices. Cost of revenue rose 385%, faster than revenue.
- FY2022 results included $4.8 million of long-lived-asset impairment and $1.6 million of goodwill impairment, both tied to Hitrans underperformance. The company also recorded $7.7 million of loss on disposal of property, plant and equipment and a $5.7 million non-cash warrant fair-value gain. The prior-year $61.8 million warrant gain substantially elevated FY2021 earnings.
- At year-end, cash and cash equivalents were $6.5 million and pledged deposits were $30.8 million, for $37.4 million combined. Pledged deposits are restricted collateral, not freely available cash. Current assets were $125.7 million and current liabilities $111.9 million, a $13.8 million working-capital surplus.
- Year-end debt and payment obligations included $14.9 million of short-term bank borrowings, $0.7 million of other short-term loans, and $35.0 million of bills payable. Trade payables were $32.5 million. The filing describes substantial short-term obligations and reliance on renewing or obtaining financing.
- Capital expenditures were $12.4 million in 2022. Management estimated approximately $80 million of FY2023 capital expenditures for plants and production lines.
Material changes and management outlook
- Hitrans materials revenue rose to $154.0 million from $17.9 million, partly because FY2022 included a full year of operations versus roughly one month in FY2021. CBAK’s ownership was 67.33% of registered equity at year-end after Hitrans financing and an equity-interest transfer.
- UPS battery revenue increased 151% to $83.6 million; light electric vehicle battery revenue increased to $6.4 million from $0.7 million. EV battery revenue was $4.7 million, versus $0.2 million.
- Management’s expansion plan describes a long-term Nanjing capacity target of 20 GWh annually, with Phase I at 0.7 GWh operational at year-end and a target of 2 GWh by the end of 2023. Phase II is planned to add capacity, with completion and timing subject to market acceptance and adjustment. The filing elsewhere references a different original project capacity; the precise scope and schedule should be verified.
- Management expects demand in energy storage and light electric vehicles to support growth, while noting that China’s EV purchase subsidies ended December 31, 2022. It plans to renew bank borrowings and may seek additional debt or equity financing. No firm earnings or revenue guidance is provided.
- COVID-related restrictions reduced manufacturing utilization during 2022; most restrictions were lifted in December. The company noted that future disruptions remain uncertain.
Risks, contingencies and unusual items
- The auditor issued an unmodified opinion on the financial statements but included a going-concern explanatory paragraph, stating that recurring losses and significant short-term debt obligations raise substantial doubt about the company’s ability to continue as a going concern. Management’s plans depend on improved profitability, debt renewals and additional financing; success is not assured.
- Management concluded that disclosure controls and internal control over financial reporting were ineffective at December 31, 2022. Material weaknesses include inadequate processes for accounting for key agreements and insufficient technically skilled U.S. GAAP accounting staff.
- Customer concentration increased: the top five customers represented 69.5% of revenue versus 54.0% in 2021. The company also disclosed material related-party transactions, including cathode-material sales to Zhengzhou BAK Battery.
- Other risks include volatile nickel, cobalt and lithium input costs; competition and product-acceptance uncertainty; reliance on short-term customer forecasts and suppliers; no product-liability insurance; and restrictions on moving cash from China. Nearly all operations and assets are in China, exposing the company to PRC regulatory, legal, currency and cross-border capital-transfer risks.
- The PCAOB reported full inspection access to firms in mainland China and Hong Kong in December 2022, and the company did not expect to be identified under the HFCAA after this filing. Future access could change; two consecutive years of identification could lead to a U.S. trading prohibition.
- Capital commitments totaled $163.4 million at year-end, including $137.7 million of capital injections, $21.4 million for construction and $4.2 million for equipment. A supplier-related equipment commitment also includes a potential payment if specified purchases are not completed. The filing discloses ongoing litigation over a contractor claim and a $3 million Hitrans-acquisition deposit dispute; the contractor matter’s final outcome remains unresolved.
Important facts for investors to verify
- Availability of unrestricted cash, the maturity schedule and renewal status of loans and bills payable, and whether planned financing can be secured on acceptable terms.
- Whether operating cash generation can be sustained as inventory increased to $49.4 million and whether customer receivables—particularly related-party balances—are collected as expected.
- Hitrans’ operating performance, the basis for its impairments, and the status and consideration of the announced post-year-end transfer of its controlling interest to Nanjing BFD.
- Feasibility, funding and timing of the $80 million FY2023 capital-expenditure plan and the stated capacity expansion targets.
- Remediation of the reported material weaknesses and improvement in disclosure controls; the filing states no auditor attestation on internal-control effectiveness was performed.
- Potential impact of PRC overseas-listing filing rules, PCAOB inspection access, and restrictions on cross-border cash transfers.